CCHF Letter to FDA Seven Reasons NOT to Give Full Approval to Covid-19 Vaccines

ST. PAUL, Minn. — In the past few weeks, Moderna and Pfizer have asked the Food and Drug Administration to give full approval to their investigational mRNA vaccines for COVID-19.

A rush to approval would be dangerous to Americans, wrote the Citizens’ Council for Health Freedom (CCHF) in a letter to Janet Woodcock, Acting Commissioner of the FDA, dated June 2, 2021.

“Our organization is writing to express our deep concern regarding the recent approval requests from Moderna and Pfizer. Both have asked the FDA to give full approval to their Covid-19 vaccines, which to date only have Emergency Use Authority (EUA),” wrote Twila Brase, RN, PHN, president and co-founder of CCHF. She shared seven reasons the requests should be “promptly and fully denied”:

CCHF Issues Letter to U.S. Senate Leadership Opposing Becerra Confirmation

CCHF Issues Letter to U.S. Senate Leadership Opposing Becerra Confirmation

While awaiting a Senate confirmation vote, Citizens’ Council for Health Freedom issued an urgent plea from Twila Brase to that chamber's leadership speaking out against the nomination of California Attorney General Xavier Becerra for Secretary of Health and Human Services.  Read the original letter HERE.  Read the press release HERE.

CCHF Issues Letter Against Becerra Nomination

CCHF Issues Letter Against Becerra Nomination

CCHF recently sent a letter to Sen. Tom Cotton (R-AR) opposing the nomination of Xavier Becerra for HHS Secretary.

CCHF Letter to MDH Commissioner Malcolm

CCHF Letter to MDH Commissioner Malcolm

"We are deeply concerned with your April 2 'Notification Letter' letter to Minnesota hospitals regarding 'Situational Awareness.' Whether by accident or design, your Notification Letter falsely suggests that you have the authority to compel hospitals to provide MDH with all general population patient data, rather than limited, specific and authorized data necessary to support MDH’s COVID-19 surveillance efforts. . . ."

Letter to President Trump Re: Surprise Medical Bills

Opioid Crisis Act Letter to Sen. Lamar Alexander

Opioid Crisis Act Letter to Sen. Lamar Alexander

Our organization is writing to you regarding the Opioid Crisis Response Act of 2018 (S. 2680), which was marked up yesterday. On pages 2-3, I detail just some of our concernsregarding the original bill, as the marked-up bill is not yet available, and likely parts or most remain. 

CCHF Letter to Walden, Burgess, & Barton regarding Jessie's Law

CCHF Letter to Walden, Burgess, & Barton regarding Jessie's Law

We are concerned about the impact of this legislation on patient rights, patient privacy, and patient access to timely and essential medical care. We request that the legislation NOT be passed.

CCHF Letter to President Trump - Idaho Gov. Executive Order

CCHF Letter to President Trump - Idaho Gov. Executive Order

The primary purpose of this letter is to ask you to withhold all regulatory action against the state of Idaho and Governor Butch Otter for his executive order to authorize health insurance policies that do not comply with the ACA.

CMS 2018 Medicare PAR Letter - CCHF Overview to CMS FINAL

CSR Subsidies A “Solution” in Search of a Problem and the Costly Danger of Double-Dipping

CSR Subsidies A “Solution” in Search of a Problem and the Costly Danger of Double-Dipping

On October 12, 2017, President Trump announced the immediate termination of Cost-Sharing Reduction (CSR) payments. The White House stated, “Based on guidance from the Department of Justice, the Department of Health and Human Services has concluded that there is no appropriation for cost-sharing reduction payments to insurance companies under Obamacare. In light of this analysis, the Government cannot lawfully make the cost-sharing payments.”